These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19633000)

  • 1. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
    Peeters E; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria.
    Van Acker H; Van Snick E; Nelis HJ; Coenye T
    J Cyst Fibros; 2010 Dec; 9(6):450-4. PubMed ID: 20851061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms.
    Caraher EM; Gumulapurapu K; Taggart CC; Murphy P; McClean S; Callaghan M
    J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium.
    Peeters E; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2008 May; 61(5):1062-5. PubMed ID: 18310047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM; Scott EM
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y; Yu XH; Wang R; An MM; Liang BB
    J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.
    Caraher E; Reynolds G; Murphy P; McClean S; Callaghan M
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):213-6. PubMed ID: 17265071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex.
    Veloira WG; Domenico P; LiPuma JJ; Davis JM; Gurzenda E; Kazzaz JA
    J Antimicrob Chemother; 2003 Dec; 52(6):915-9. PubMed ID: 14585856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy of disinfection procedures against Burkholderia cenocepacia biofilms.
    Peeters E; Nelis HJ; Coenye T
    J Hosp Infect; 2008 Dec; 70(4):361-8. PubMed ID: 18977555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex Bacteria.
    Van Acker H; Gielis J; Acke M; Cools F; Cos P; Coenye T
    PLoS One; 2016; 11(7):e0159837. PubMed ID: 27438061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
    Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
    Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
    Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa.
    Harrison JJ; Turner RJ; Ceri H
    Environ Microbiol; 2005 Jul; 7(7):981-94. PubMed ID: 15946294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
    Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
    Smith K; Perez A; Ramage G; Gemmell CG; Lang S
    Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Treerat P; Widmer F; Middleton PG; Iredell J; George AM
    FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.